Northern Sydney and Central Coast Area Health Service
14
6
8
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
14.3%
2 terminated/withdrawn out of 14 trials
50.0%
-36.6% vs industry average
7%
1 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Ventilation Using Radiographic Examination: Functional Lung Imaging Techniques for the Reduction of Toxicity in Functional Avoidance Radiation Therapy
Role: collaborator
Continuous Monitoring of Prostate Position During Radiotherapy
Role: collaborator
3D Printed Custom Applicators for HDR BT (DISCO)
Role: collaborator
Focal Radiotherapy for Previously Treated Prostate Cancer Patients
Role: collaborator
Advanced Techniques For Single-fraction Palliative Radiotherapy Versus Standard Multi Fraction Radiation
Role: collaborator
Breast Fractionation Study - Standard Versus Investigational Fractionation Trial - Nodal Radiation
Role: collaborator
Pelvis Adaptive Radiotherapy (ART)
Role: collaborator
Prostate Adaptive Radiation Therapy
Role: collaborator
Transition of Care in Type 1 Diabetes Mellitus
Role: lead
Prevention of Postoperative Events Following Reversal With Sugammadex or Neostigmine
Role: collaborator
VISIBLE Study (Visual Intervention Strategy Incorporating Bifocal & Long-distance Eyewear)
Role: collaborator
Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene
Role: lead
Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer
Role: collaborator
Management of Common Bile Duct (CBD) Stones at Laparoscopic Cholecystectomy
Role: collaborator
All 14 trials loaded